Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | OT |
got Covid about 2 years ago; got Covid about 2 years ago; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOD-2025-789858 (Moderna Clinical Safety and Pharmacovigilance). A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) and as dose number unknown, single (Batch/Lot number: unknown), all intramuscular for covid-19 immunisation; elasomeran (SPIKEVAX), as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history included: "Respiratory disorder" (ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "recovered" and all described as "got Covid about 2 years ago". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: it was reported that patient got COVID about 2 years ago after having multiple vaccines. Patient had COVID for 3 weeks though had treatment medication of Paxlovid. It was interpreted that got COVID because always had Moderna vaccines and had gotten Pfizer which was premature. The patient was unable to take penicillin but it was not explained the reason. It was unknown if the patient experienced any additional symptoms or events. Moderna comment: The benefit-risk relationship of the product (Spikevax) is not affected by this report. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Respiratory disorder